Lisinopril Patent Expiration

Lisinopril is Used for treating acute myocardial infarction, hypertension, and heart failure. It was first introduced by Merck Research Laboratories Div Merck Co Inc in its drug Prinivil on Dec 29, 1987. Other drugs containing Lisinopril are Zestril, Qbrelis. 20 different companies have introduced drugs containing Lisinopril.


Lisinopril Patents

Given below is the list of patents protecting Lisinopril, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Qbrelis US10039800 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10265370 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10406199 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10940177 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US11179434 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US11771733 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9463183 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9616096 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9814751 Lisinopril formulations Nov 06, 2035 Azurity


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lisinopril's patents.

Given below is the list recent legal activities going on the following patents of Lisinopril.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 11 Apr, 2024 US9463183
Patent Issue Date Used in PTA Calculation 03 Oct, 2023 US11771733
Mail Patent eGrant Notification 03 Oct, 2023 US11771733
Recordation of Patent Grant Mailed 03 Oct, 2023 US11771733
Email Notification 03 Oct, 2023 US11771733
Recordation of Patent eGrant 03 Oct, 2023 US11771733
Patent eGrant Notification 03 Oct, 2023 US11771733
Email Notification 15 Sep, 2023 US11771733
Issue Notification Mailed 13 Sep, 2023 US11771733
Dispatch to FDC 24 Aug, 2023 US11771733



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Lisinopril Generics

Several generic applications have been filed for Lisinopril. The first generic version for Lisinopril was by Heritage Pharma Labs Inc and was approved on Jul 1, 2002. And the latest generic version is by Sciegen Pharmaceuticals Inc and was approved on Mar 4, 2021.

Given below is the list of companies who have filed for Lisinopril generic.


1. HERITAGE PHARMA

Heritage Pharma Labs Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Heritage Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG tablet Discontinued ORAL N/A Jul 1, 2002
40MG tablet Discontinued ORAL N/A Jul 1, 2002
2.5MG tablet Discontinued ORAL N/A Jul 1, 2002
5MG tablet Discontinued ORAL N/A Jul 1, 2002
10MG tablet Discontinued ORAL N/A Jul 1, 2002
20MG tablet Discontinued ORAL N/A Jul 1, 2002


2. HIKMA INTL PHARMS

Hikma International Pharmaceuticals Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Discontinued ORAL N/A Jul 1, 2002
5MG tablet Discontinued ORAL N/A Jul 1, 2002
10MG tablet Discontinued ORAL N/A Jul 1, 2002
20MG tablet Discontinued ORAL N/A Jul 1, 2002
40MG tablet Discontinued ORAL N/A Jul 1, 2002
30MG tablet Discontinued ORAL N/A Jun 27, 2003


3. LUPIN

Lupin Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG tablet Prescription ORAL AB Sep 9, 2005
2.5MG tablet Prescription ORAL AB Sep 9, 2005
5MG tablet Prescription ORAL AB Sep 9, 2005
10MG tablet Prescription ORAL AB Sep 9, 2005
20MG tablet Prescription ORAL AB Sep 9, 2005
40MG tablet Prescription ORAL AB Sep 9, 2005


4. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG tablet Discontinued ORAL N/A Jul 30, 2013
2.5MG tablet Discontinued ORAL N/A Jul 30, 2013
30MG tablet Discontinued ORAL N/A Jul 30, 2013
5MG tablet Discontinued ORAL N/A Jul 30, 2013
10MG tablet Discontinued ORAL N/A Jul 30, 2013
40MG tablet Discontinued ORAL N/A Jul 30, 2013


5. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Discontinued ORAL N/A Jul 1, 2002
5MG tablet Discontinued ORAL N/A Jul 1, 2002
10MG tablet Discontinued ORAL N/A Jul 1, 2002
20MG tablet Discontinued ORAL N/A Jul 1, 2002
30MG tablet Discontinued ORAL N/A Jul 1, 2002
40MG tablet Discontinued ORAL N/A Jul 1, 2002


6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Jul 1, 2002
5MG tablet Prescription ORAL AB Jul 1, 2002
10MG tablet Prescription ORAL AB Jul 1, 2002
20MG tablet Prescription ORAL AB Jul 1, 2002
30MG tablet Prescription ORAL AB Jul 1, 2002
40MG tablet Prescription ORAL AB Jul 1, 2002


7. WATSON LABS

Watson Laboratories Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Jul 1, 2002
5MG tablet Prescription ORAL AB Jul 1, 2002
10MG tablet Prescription ORAL AB Jul 1, 2002
20MG tablet Prescription ORAL AB Jul 1, 2002
30MG tablet Prescription ORAL AB Jul 1, 2002
40MG tablet Prescription ORAL AB Jul 1, 2002


8. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG tablet Prescription ORAL AB Oct 29, 2013
2.5MG tablet Prescription ORAL AB Oct 29, 2013
5MG tablet Prescription ORAL AB Oct 29, 2013
10MG tablet Prescription ORAL AB Oct 29, 2013
20MG tablet Prescription ORAL AB Oct 29, 2013
40MG tablet Prescription ORAL AB Oct 29, 2013


9. TEVA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Discontinued ORAL N/A Jul 1, 2002
5MG tablet Discontinued ORAL N/A Jul 1, 2002
10MG tablet Discontinued ORAL N/A Jul 1, 2002
20MG tablet Discontinued ORAL N/A Jul 1, 2002
30MG tablet Discontinued ORAL N/A Jul 1, 2002
40MG tablet Discontinued ORAL N/A Jul 1, 2002


10. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Jul 1, 2002
5MG tablet Prescription ORAL AB Jul 1, 2002
10MG tablet Prescription ORAL AB Jul 1, 2002
20MG tablet Prescription ORAL AB Jul 1, 2002
40MG tablet Prescription ORAL AB Jul 1, 2002
30MG tablet Prescription ORAL AB Feb 11, 2003


11. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Discontinued ORAL N/A Jul 1, 2002
5MG tablet Discontinued ORAL N/A Jul 1, 2002
10MG tablet Discontinued ORAL N/A Jul 1, 2002
20MG tablet Discontinued ORAL N/A Jul 1, 2002
30MG tablet Discontinued ORAL N/A Jul 1, 2002
40MG tablet Discontinued ORAL N/A Jul 1, 2002


12. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG tablet Prescription ORAL AB Apr 19, 2007
2.5MG tablet Prescription ORAL AB Apr 19, 2007
5MG tablet Prescription ORAL AB Apr 19, 2007
10MG tablet Prescription ORAL AB Apr 19, 2007
20MG tablet Prescription ORAL AB Apr 19, 2007
30MG tablet Prescription ORAL AB Apr 19, 2007


13. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Sep 15, 2020
10MG tablet Prescription ORAL AB Sep 15, 2020
5MG tablet Prescription ORAL AB Sep 15, 2020
40MG tablet Prescription ORAL AB Mar 4, 2021
30MG tablet Prescription ORAL AB Mar 4, 2021
20MG tablet Prescription ORAL AB Mar 4, 2021


14. COREPHARMA

Corepharma Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Sep 30, 2002
40MG tablet Prescription ORAL AB Sep 30, 2002
30MG tablet Prescription ORAL AB Sep 30, 2002
20MG tablet Prescription ORAL AB Sep 30, 2002
10MG tablet Prescription ORAL AB Sep 30, 2002
5MG tablet Prescription ORAL AB Sep 30, 2002


15. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Jul 1, 2002
10MG tablet Prescription ORAL AB Jul 1, 2002
20MG tablet Prescription ORAL AB Jul 1, 2002
30MG tablet Prescription ORAL AB Jul 1, 2002
40MG tablet Prescription ORAL AB Jul 1, 2002
5MG tablet Prescription ORAL AB Jul 1, 2002


16. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Jul 1, 2002
5MG tablet Prescription ORAL AB Jul 1, 2002
10MG tablet Prescription ORAL AB Jul 1, 2002
20MG tablet Prescription ORAL AB Jul 1, 2002
30MG tablet Prescription ORAL AB Jul 1, 2002
40MG tablet Prescription ORAL AB Jul 1, 2002


17. AUROBINDO

Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Aurobindo.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB Feb 22, 2006
2.5MG tablet Prescription ORAL AB Feb 22, 2006
10MG tablet Prescription ORAL AB Feb 22, 2006
20MG tablet Prescription ORAL AB Feb 22, 2006
30MG tablet Prescription ORAL AB Feb 22, 2006
40MG tablet Prescription ORAL AB Feb 22, 2006